Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial-Reference-Cited by-同舟云学术

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial

Published:2011-08 Issue:2 Volume:122 Page:215-220
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Deraco Marcello,Kusamura Shigeki,Virzì Salvatore,Puccio Francesco,Macrì Antonio,Famulari Ciro,Solazzo Massimiliano,Bonomi Serena,Iusco Domenico Rosario,Baratti Dario

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference49 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Ovarian cancer;Hennessy;Lancet,2009

3. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and IV EOC;McGuire;N Engl J Med,1996

4. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study;Ozols;J Clin Oncol,2003

5. Interval debulking surgery for advanced epithelial ovarian cancer;Tangjitgamol;Cochrane Database Syst Rev,2010

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperthermic intraperitoneal chemotherapy (HIPEC) vs. postoperative intraperitoneal (IP) chemotherapy – Impact on health-related quality of life in primary ovarian cancer patients after cytoreductive surgery;Surgical Oncology Insight;2024-09

2. Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on epithelial ovarian, fallopian tube, and peritoneal cancer: An institutional review of outcomes and its clinical implications;Philippine Journal of Obstetrics and Gynecology;2024-01

3. Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods;International Journal of Gynecologic Cancer;2023-09-05

4. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Epithelial Ovarian Cancer;Annals of Surgical Oncology;2023-08-10

5. HIPEC for gynaecological malignancies: A last update (Review);Medicine International;2023-05-04